Brain-Gut-Microbiota Axis and Mental Health

Psychosomatic Medicine

Volumn 79, Issue 8, 2017, Pages 920-926

  Dinan, Timothy G ^a,b   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

anxiety; autism; brain gut microbiota axis; depression; psychobiotics; schizophrenia

Indexed keywords

ANXIETY DISORDER; AUTISM; BIFIDOBACTERIUM LONGUM; BRAIN GUT INTERACTION; CENTRAL NERVOUS SYSTEM FUNCTION; DEPRESSION; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; EVIDENCE BASED MEDICINE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INTESTINE FLORA; MENTAL HEALTH; NONHUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL WELL-BEING; PUBLICATION; REVIEW; SCHIZOPHRENIA; ANIMAL; BRAIN; COMPLICATION; DRUG EFFECT; DYSBIOSIS; MENTAL DISEASE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

PROBIOTIC AGENT;

ANIMALS; BRAIN; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUMANS; MENTAL DISORDERS; PROBIOTICS; SIGNAL TRANSDUCTION;

EID: 85031307275     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000519     Document Type: Review

References (65)

1. Chertok L. 30 years later. The story of the discovery of neuroleptics. Ann Med Psychol (Paris) 1982;140:971-6
2. Wardt-Kikkert NM, Rentmeester J. The use of largactil in psychiatry. Geneeskd Gids 1953;31:499-507
3. Domino EF. History of modern psychopharmacology: a personal view with an emphasis on antidepressants. Psychosom Med 1999;61:591-8
4. Lopez-Munoz F, Alamo C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des 2009; 15:1563-86
5. Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 2000;61(Suppl 6):4-6
6. Stanniland C, Taylor D. Tolerability of atypical antipsychotics. Drug Saf 2000; 22:195-214
7. Khoury B, Knäuper B, Schlosser M, Carrière K, Chiesa A. Effectiveness of traditional meditation retreats: a systematic review and meta-analysis. J Psychosom Res 2017;92:16-25
8. Coronado-Montoya S, Levis AW, Kwakkenbos L, Steele RJ, Turner EH, Thombs BD. Reporting of positive results in randomized controlled trials of mindfulness-based mental health interventions. PLoS One 2016;11:e0153220
9. Lilja JL, Zelleroth C, Axberg U, Norlander T. Mindfulness-based cognitive therapy is effective as relapse prevention for patients with recurrent depression in Scandinavian primary health care. Scand J Psychol 2016;57:464-72
10. Cladder-Micus MB, Vrijsen JN, Becker ES, Donders R, Spijker J, Speckens AE. A randomized controlled trial of mindfulness-based cognitive therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol. BMC Psychiatry 2015;15:275
11. Furukawa TA, Noma H, Caldwell DM, Honyashiki M, Shinohara K, Imai H, Chen P, Hunot V, Churchill R.Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatr Scand 2014;130:181-92
12. Mayer EA,Knight R,Mazmanian SK, Cryan JF, TillischK.Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 2014;34:15490-6
13. Dinan TG, Cryan JF. The impact of gutmicrobiota on brain and behaviour: implications for psychiatry. Curr Opin Clin Nutr Metab Care 2015;18:552-8
14. Dinan TG, Cryan JF. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol 2017;595:489-503
15. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-entericmicrobiota axis. Nat RevGastroenterol Hepatol 2009;6:306-14
16. El Aidy S, Dinan TG, Cryan JF. Gut microbiota: the conductor in the orchestra of immune-neuroendocrine communication. Clin Ther 2015;37:954-67
17. GrenhamS, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol 2011;2:94
18. Dinan TG, Stilling RM, Stanton C, Cryan JF. Collective unconscious: how gut microbes shape human behavior. J Psychiatr Res 2015;63:1-9
19. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 2011;108:16050-5
20. Svensson E, Horvath-Puho E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, Sorensen HT. Vagotomy and subsequent risk of Parkinson's disease. Ann Neurol 2015;78:522-9
21. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic Bifidobacteriuminfantis in thematernal separationmodel of depression. Neuroscience 2010;170:1179-88
22. LyteM.Microbial endocrinology in the microbiome-gut-brain axis: howbacterial production and utilization of neurochemicals influence behavior. PLoS Pathog 2013;9:e1003726
23. Lyte M. Microbial endocrinology and the microbiota-gut-brain axis. Adv Exp Med Biol 2014;817:3-24
24. Stilling RM, Dinan TG, Cryan JF. Microbial genes, brain &behaviour-epigenetic regulation of the gut-brain axis. Genes Brain Behav 2014;13:69-86
25. El Aidy S, Dinan TG, Cryan JF. Immune modulation of the brain-gut-microbe axis. Front Microbiol 2014;5:146
26. Capuron L, Hauser P, Hinze-Selch D, Miller AH, Neveu PJ. Treatment of cytokine-induced depression. Brain Behav Immun 2002;16:575-80
27. Abautret-Daly A, Dempsey E, Parra-Blanco A, Medina C, Harkin A. Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatr 2017:1-22
28. O'Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, Cryan JF, Dinan TG. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 2009;65:263-7
29. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y,WangW, TangW, Tan Z, Shi J, Li L, Ruan B. Altered fecal microbiota composition in patientswithmajor depressive disorder. Brain Behav Immun 2015;48:186-94
30. Kelly JR, Borre Y, O' Brien C, Patterson E, El Aidy S, Deane J, Kennedy PJ, Beers S, Scott K, Moloney G, Hoban AE, Scott L, Fitzgerald P, Ross P, Stanton C, Clarke G, Cryan JF, Dinan TG. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 2016;82:109-18
31. Lin H, Williams KA, Katsovich L, Findley DB, Grantz H, Lombroso PJ, King RA, Bessen DE, Johnson D, Kaplan EL, Landeros-Weisenberger A, Zhang H, Leckman JF. Streptococcal upper respiratory tract infections and psychosocial stress predict future tic and obsessive-compulsive symptom severity in children and adolescents with Tourette syndrome and obsessive-compulsive disorder. Biol Psychiatry 2010;67:684-91
32. Kantak PA, Bobrow DN, Nyby JG. Obsessive-compulsive-like behaviors in house mice are attenuated by a probiotic (Lactobacillus rhamnosus GG). Behav Pharmacol 2014;25:71-9
33. Lyte M, Varcoe JJ, Bailey MT. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol Behav 1998;65:63-8
34. Bruch JD. Intestinal infection associated with future onset of an anxiety disorder: results of a nationally representative study. Brain Behav Immun 2016;57:222-6
35. Zahorodny W, Shenouda J, Howell S, Rosato NS, Peng B, Mehta U. Increasing autism prevalence in metropolitan New Jersey. Autism 2014;18:117-26
36. Li Q, Zhou JM. The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder. Neuroscience 2016;324:131-9
37. Borre YE, O'Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med 2014;20:509-18
38. Desbonnet L, Clarke G, Shanahan F, Dinan TG, Cryan JF. Microbiota is essential for social development in the mouse. Mol Psychiatry 2014;19:146-8
39. Borre YE, Moloney RD, Clarke G, Dinan TG, Cryan JF. The impact of microbiota on brain and behavior: mechanisms &therapeutic potential. Adv Exp Med Biol 2014;817:373-403
40. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH,Mazmanian SK.Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013;155:1451-63
41. Chini B, Leonzino M, Braida D, Sala M. Learning about oxytocin: pharmacologic and behavioral issues. Biol Psychiatry 2014;76:360-6
42. Shen H. Neuroscience: the hard science of oxytocin. Nature 2015;522:410-2
43. Erdman SE, Poutahidis T. Probiotic 'glow of health': it's more than skin deep. Benef Microbes 2014;5:109-19
44. Buffington SA, Di Prisco GV, Auchtung TA, Ajami NJ, Petrosino JF, Costa-Mattioli M. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 2016;165:1762-75
45. Tomova A, Husarova V, Lakatosova S, Bakos J, Vlkova B, Babinska K, Ostatnikova D. Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav 2015;138:179-87
46. Son JS, Zheng LJ, Rowehl LM, Tian X, Zhang Y, Zhu W. Comparison of faecal microbiota in children with autism spectrum disorders and neurotypical siblings in the Simons Simplex Collection. Plos One 2015;10:e0137725
47. MolloyMJ, Grainger JR, Bouladoux N, HandTW, Koo LY, Naik S,QuinonesM, Dzutsev AK, Gao JL, Trinchieri G, MurphyPM, Belkaid Y. Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe 2013;14:318-28
48. Bhadra R, Cobb DA, Weiss LM, Khan IA. Psychiatric disorders in toxoplasma seropositive patients-The CD8 connection. Schizophr Bull 2013;39:485-9
49. Vyas A, Kim SK, Giacomini N, Boothroyd JC, Sapolsky RM. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc Natl Acad Sci U S A 2007;104:6442-7
50. Beste C, Getzmann S, Gajewski PD, Golka K, FalkensteinM. Latent Toxoplasma gondii infection leads to deficits in goal-directed behavior in healthy elderly. Neurobiol Aging 2014;35:1037-44
51. Shaw W. Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. Nutr Neurosci 2010;13:135-43
52. Dinan TG, Borre YE, Cryan JF. Genomics of schizophrenia: time to consider the gut microbiome? Mol Psychiatry 2014;19:1252-7
53. Selhub EM, Logan AC, Bested AC. Fermented foods, microbiota, and mental health: ancient practicemeets nutritional psychiatry. J PhysiolAnthropol 2014;33:2
54. Nanri A, KimuraY, MatsushitaY, Ohta M, Sato M, MishimaN, Sasaki S,Mizoue T. Dietary patterns and depressive symptoms among Japanese men and women. Eur J Clin Nutr 2010;64:832-9
55. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry 2013;74:720-6
56. Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World J Gastroenterol 2015;21:3072-84
57. Kelly JR, Allen AP, Temko A, Hutch W, Kennedy PJ, Farid N, Murphy E, Boylan G, Bienenstock J, Cryan JF, Clarke G, Dinan TG. Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav Immun 2017;61:50-9
58. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, GuyonnetD, Legrain-Raspaud S, Trotin B, Naliboff B, Mayer EA. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013;144: 1394-401, 1401 e1391-e1394
59. Schmidt K, Cowen PJ, Harmer CJ, Tzortzis G, Errington S, Burnet PW. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl) 2015;232:1793-801
60. Bhagwagar Z, Hafizi S, Cowen PJ. Increased salivary cortisol after waking in depression. Psychopharmacology (Berl) 2005;182:54-7
61. TakadaM,Nishida K, Kataoka-Kato A,GondoY, Ishikawa H, SudaK,Kawai M, Hoshi R,Watanabe O, Igarashi T, Kuwano Y, Miyazaki K, Rokutan K. Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models. Neurogastroenterol Motil 2016;28:1027-36
62. Hilimire MR, DeVylder JE, Forestell CA. Fermented foods, neuroticism, and social anxiety: an interaction model. Psychiatry Res 2015;228:203-8
63. Steenbergen L, Sellaro R, van Hemert S, Bosch JA, Colzato LS. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 2015;48:258-64
64. Romijn AR, Rucklidge JJ. Systematic review of evidence to support the theory of psychobiotics. Nutr Rev 2015;73:675-93
65. Dinan TG, Cryan JF. The microbiome-gut-brain axis in health and disease. Gastroenterol Clin North Am 2017;46:77-89